Skip to content

Exploration of the current status and influencing factors of peak inspiratory flow rate in patients with COPD and asthma: A cross-sectional study

Exploration of the current status and influencing factors of PIFR in patients with COPD and asthma: A cross-sectional study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111908
Enrollment
Unknown
Registered
2025-11-07
Start date
2025-08-20
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, chronic obstructive pulmonary disease

Interventions

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with COPD diagnosed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD-2024) criteria or patients with bronchial asthma diagnosed according to the Global Initiative for Asthma (GINA-2024) criteria; 2. Maintenance treatment with Ellipta, expected for at least 3 months or more; 3. Age greater than 18 years.

Exclusion criteria

Exclusion criteria: 1. Due to physical or mental conditions that prevent them from cooperating with pulmonary function tests or PIFR measurement techniques; 2. Also participating in other drug or pulmonary rehabilitation clinical trials.

Design outcomes

Primary

MeasureTime frame
Peak inspiratory flow rate;

Secondary

MeasureTime frame
Lung function;

Countries

China

Contacts

Public ContactXuan Long

Shanghai Tenth People's Hospital

295457030@qq.com+86 156 1878 7621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026